
|Articles|March 26, 2020
COVID 19: How life/work has changed for German ophthalmologists
Author(s)Alex Delaney-Gesing
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Eli Lilly to acquire Adverum Biotechnologies
2
Regeneron receives another CRL for its Eylea 8 mg
3
Anti-VEGF innovations in retinal disease: From molecules to medicine
4
SparingVision doses first patient in NYRVANA clinical trial of SPVN20 for retinitis pigmentosa
5


















































.png)


